Literature DB >> 24704046

Unusual splice site mutations disrupt FANCA exon 8 definition.

Chiara Mattioli1, Giulia Pianigiani1, Daniela De Rocco2, Anna Monica Rosaria Bianco2, Enrico Cappelli3, Anna Savoia4, Franco Pagani5.   

Abstract

The pathological role of mutations that affect not conserved splicing regulatory sequences can be difficult to determine. In a patient with Fanconi anemia, we identified two unpredictable splicing mutations that act on either sides of FANCA exon 8. In patients-derived cells and in minigene splicing assay, we showed that both an apparently benign intronic c.710-5T>C transition and the nonsense c.790C>T substitution induce almost complete exon 8 skipping. Site-directed mutagenesis experiments indicated that the c.710-5T>C transition affects a polypyrimidine tract where most of the thymidines cannot be compensated by cytidines. The c.790C>T mutation located in position -3 relative to the donor site induce exon 8 skipping in an NMD-independent manner and complementation experiments with modified U1 snRNAs showed that U1 snRNP is only partially involved in the splicing defect. Our results highlight the importance of performing splicing functional assay for correct identification of disease-causing mechanism of genomic variants and provide mechanistic insights on how these two FANCA mutations affect exon 8 definition.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fanconi anemia; Nonsense codon; Nonsense mediated mRNA decay; RNA splice sites; RNA splicing; U1 small nuclear ribonucleoprotein

Mesh:

Substances:

Year:  2014        PMID: 24704046     DOI: 10.1016/j.bbadis.2014.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

Review 1.  We are all individuals... bioinformatics in the personalized medicine era.

Authors:  Leander Van Neste; Wim Van Criekinge
Journal:  Cell Oncol (Dordr)       Date:  2014-09-10       Impact factor: 6.730

2.  Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations.

Authors:  Liliana Matos; Isaac Canals; Larbi Dridi; Yoo Choi; Maria João Prata; Peter Jordan; Lourdes R Desviat; Belén Pérez; Alexey V Pshezhetsky; Daniel Grinberg; Sandra Alves; Lluïsa Vilageliu
Journal:  Orphanet J Rare Dis       Date:  2014-12-10       Impact factor: 4.123

3.  Facial cutaneo-mucosal venous malformations can develop independently of mutation of TEK gene but may be associated with excessive expression of Src and p-Src.

Authors:  Nabila Brahami; Selvakumar Subramaniam; Moudjahed Saleh Al-Ddafari; Cecile Elkaim; Pierre-Olivier Harmand; Badr-Eddine Sari; Gérard Lefranc; Mourad Aribi
Journal:  J Negat Results Biomed       Date:  2017-03-20

4.  Single-nucleotide substitution T to A in the polypyrimidine stretch at the splice acceptor site of intron 9 causes exon 10 skipping in the ACAT1 gene.

Authors:  Hideo Sasai; Yuka Aoyama; Hiroki Otsuka; Elsayed Abdelkreem; Mina Nakama; Tomohiro Hori; Hidenori Ohnishi; Lesley Turner; Toshiyuki Fukao
Journal:  Mol Genet Genomic Med       Date:  2017-02-08       Impact factor: 2.183

5.  Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia.

Authors:  Nils W Engel; Simon Schliffke; Ulrich Schüller; Christian Frenzel; Carsten Bokemeyer; Christian Kubisch; Davor Lessel
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.